NCT03947866

Ezetimibe-Rosuvastatin Evaluation Study

An Observational Clinical Study to Evaluate the Effectiveness of Fixed-dose Combination of eZEtimibe-rosUvaStatin.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 600 (estimated)
• Sponsor: Elpen Pharmaceutical Co. Inc. · Industry
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

Evaluation of the efficacy of the stable ezetimibe-rosuvastatin combination in patients with primary hypercholesterolemia in achieving the target plasma LCL-C level.

Detailed description

Additional study objectives: 1. Evaluation of the efficacy of the stable ezetimibe-rosuvastatin combination in patients with primary hypercholesterolemia with respect to changes in the rest of the lipid profile (HDL-C, TC, TG). 2. Evaluation of the efficacy of the stable ezetimibe-rosuvastatin combination in patients with primary hypercholesterolemia in altering non-HDL cholesterol (non-HDL - cholesterol) levels. 3. The assessment of the achievement of the LCL-C target of patients receiving the stable ezetimibe-rosuvastatin combination according to their cardiovascular risk category. 4. Assessing patient safety throughout treatment.

Conditions

• Hypercholesterolemia
• Hyperlipidemias
• Combinations of Drugs; Dependence

Timeline

• Start date: 2022-09-30
• Primary completion: 2023-09-30
• Completion: 2023-09-30
• First posted: 2019-05-13
• Last updated: 2023-02-16

Locations

1 site across 1 country: Greece